+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neurology Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 194 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889067
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurology devices market is advancing swiftly as healthcare systems prioritize innovative neurological care solutions, unlocking substantial pathways for cross-sector partnership and operational agility.

Market Snapshot: Neurology Devices Market Growth and Investment Landscape

The neurology devices market is experiencing notable global expansion, fueled by heightened investment and an accelerated focus on advanced technologies supporting neurological care. This surge is linked to a greater prevalence of neurological disorders and a demand for innovative monitoring and interventional platforms. Growth is further sustained by the adoption of interconnected devices and an expansion in therapeutic applications, which foster a comprehensive and dynamic product development pipeline. Ongoing advancement in digital health integration and strengthened platform interoperability continues to extend the market’s presence in both mature and evolving healthcare environments, providing a fertile ground for competitive differentiation and strategic investment.

Scope & Segmentation of the Neurology Devices Market

  • Product Categories: Comprises cerebrospinal fluid management systems (including external drainage equipment and shunt devices); interventional products such as embolic coils, flow diversion tools, liquid embolic agents, balloon angioplasty systems, carotid artery stents, filters, clot retrieval devices, neurothrombectomy tools, and neurovascular catheters; neurostimulation platforms for deep brain, spinal cord, sacral, vagus nerve, and gastric electric stimulation; and essential neurosurgical equipment such as aneurysm clips, neuroendoscopes, stereotactic devices, and ultrasonic aspirators.
  • Application Areas: Enable chronic pain management, diagnosis and continuous monitoring of neurological conditions (e.g., epilepsy, seizure disorders), and support interventions for mental health, including depression, anxiety, and schizophrenia. Devices also facilitate treatment for multiple sclerosis, neurodegenerative diseases (Alzheimer’s, Parkinson’s, ALS, Huntington’s), neurovascular disorders, spinal cord injuries, stroke (acute and rehabilitation phases), and traumatic brain injuries.
  • End Users: Serve research and academic centers, diagnostic facilities, hospitals, specialty neurology and rehabilitation clinics, and home care organizations, supporting deployment in diverse medical environments for well-rounded patient care.
  • Distribution Channels: Rely on high-volume procurement through offline distributor networks and hospital contracts, with online platforms enhancing access to specialized solutions for broader patient groups and at-home care.
  • Regional Coverage: Includes established healthcare markets in the Americas (United States, Canada, Brazil, Mexico), diverse adoption rates in EMEA (United Kingdom, Germany, France, Saudi Arabia, South Africa, Israel), and rapid market modernization throughout Asia-Pacific (China, India, Japan, Australia, South Korea, Singapore).
  • Technology Spectrum: Incorporates artificial intelligence, robotics, high-resolution imaging, remote monitoring, digital health interoperability, and innovative implantable neuromodulation devices, each driving enhanced clinical workflow and operational productivity.

Key Takeaways for Neurology Devices Decision-Makers

  • Artificial intelligence and robotics contribute to greater diagnostic accuracy and patient management efficiency, facilitating broader scalability in neurological care delivery.
  • Remote monitoring and telehealth provide access to both acute and long-term neurological support, enabling continuity of care beyond traditional hospital environments.
  • Real-time data exchange and interoperability standards promote organizational efficiency and best-practice clinical performance.
  • Cross-sector partnerships, including manufacturers, research institutions, and technology firms, streamline regulatory approvals and improve time-to-market for emerging products.
  • Adaptable product portfolios and responsive service models address the wide-ranging needs of specialty clinics, hospital systems, and home care providers within an increasingly segmented market.
  • Strategic investments and alliances are instrumental in scaling neurostimulation and bioelectronic therapies, influencing the pace of sector evolution and adoption.

Tariff Impact: How Policy Drives Supply Chain Strategy

Recent changes in U.S. tariffs have redefined cost structures for neurology devices, particularly for components such as specialty metals and microelectronics. Manufacturers are responding with initiatives like supplier diversification, dual sourcing, and seeking tariff exemptions for essential medical products. Expanded contract manufacturing and localized production are actively explored to maintain supply chain reliability and mitigate policy risks.

Methodology & Data Sources

A combination of interviews with clinicians, technical experts, and procurement professionals, alongside a detailed review of regulatory filings and clinical evidence, underpins this analysis. Technology maturity and device adoption are validated through standardized scoring systems to ensure tangible insights for all stakeholders.

Why This Report Matters: Actionable Insights for Stakeholders

  • Comprehensive segmentation by product type, application, user environment, and geography supports precise market positioning and strategic planning for enterprises in the neurology devices market.
  • The review of evolving technologies and regulatory landscapes enables decision-makers to nurture key partnerships and build agile, resilient supply chains.
  • The report offers clear, actionable information for senior leadership responsible for operational benchmarking and solution development tailored to the complexities of neurological care.

Conclusion

This assessment delivers concise, practical guidance to executives seeking to strengthen operational flexibility, foster innovation, and build resilience in the evolving neurology devices sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Growth and integration of AI-enabled portable EEG wearables for continuous home epilepsy monitoring
5.2. Advances in closed-loop deep brain stimulation devices offering adaptive therapy for Parkinson’s disease management
5.3. Rising adoption of noninvasive transcranial magnetic stimulation devices for treatment-resistant major depressive disorder
5.4. Emergence of implantable wireless neurostimulation systems with smartphone connectivity for chronic neuropathic pain relief
5.5. Development of high-density intracortical electrode arrays enabling real-time brain-computer interface control in paralysis rehabilitation
5.6. Expansion of miniaturized wearable near-infrared spectroscopy devices for noninvasive monitoring in stroke recovery programs
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Neurology Devices Market, by Product
8.1. CSF Management Devices
8.1.1. Cerebral External Drainage
8.1.2. Cerebral Shunts
8.2. Interventional Neurology
8.2.1. Aneurysm Coiling and Embolization
8.2.1.1. Embolic Coils
8.2.1.2. Flow Diversion Devices
8.2.1.3. Liquid Embolic Reagents
8.2.2. Cerebral Balloon Angioplasty & Stents
8.2.2.1. Balloon Occlusion Devices
8.2.2.2. Carotid Artery Stents
8.2.2.3. Filter Devices
8.2.3. Neurothromobectomy
8.2.3.1. Clot Retrievers
8.2.3.2. Snare Devices
8.2.3.3. Suction Aspiration Devices
8.2.4. Neurovascular Catheters
8.3. Neurostimulation
8.3.1. Deep Brain Stimulation
8.3.2. Gastric Electric Stimulation
8.3.3. Sacral Nerve Stimulation
8.3.4. Spinal Cord Stimulation
8.3.5. Vagus Nerve Stimulation
8.4. Neurosurgery Devices
8.4.1. Aneurysm Clips
8.4.2. Neuroendoscopes
8.4.3. Stereotactic Systems
8.4.4. Ultrasonic Aspirators
9. Neurology Devices Market, by Application
9.1. Chronic Pain
9.2. Epilepsy & Seizure Disorders
9.2.1. Diagnosis & Monitoring of Epilepsy
9.2.2. Seizure Control Devices
9.3. Mental Health Disorders
9.3.1. Anxiety
9.3.2. Depression
9.3.3. Schizophrenia
9.4. Multiple Sclerosis (MS)
9.5. Neurodegenerative Disorders
9.5.1. Alzheimer’s Disease
9.5.2. Amyotrophic Lateral Sclerosis (ALS)
9.5.3. Huntington’s Disease
9.5.4. Parkinson’s Disease
9.6. Neurovascular Disorders
9.7. Spinal Cord Injuries
9.8. Stroke
9.8.1. Hemorrhagic Stroke Devices
9.8.2. Ischemic Stroke Devices
9.8.3. Stroke Rehabilitation Devices
9.9. Traumatic Brain Injury (TBI)
10. Neurology Devices Market, by End User
10.1. Academic & Research Institutes
10.2. Diagnostic Centers
10.3. Home Care
10.4. Hospitals
10.5. Neurology Clinics
10.6. Rehabilitation Centers
11. Neurology Devices Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Neurology Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Neurology Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Neurology Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Acandis GmbH
15.3.3. B. Braun SE
15.3.4. Boston Scientific Corporation
15.3.5. Esaote SpA
15.3.6. GE HealthCare Technologies, Inc.
15.3.7. Integra LifeSciences Holdings
15.3.8. Koninklijke Philips N.V.
15.3.9. Masimo Corporation
15.3.10. Medtronic PLC
15.3.11. MicroPort Scientific Corporation
15.3.12. Natus Medical Inc.
15.3.13. Nihon Kohden Corporation
15.3.14. Penumbra Inc.
15.3.15. Rapid Medical Ltd.
15.3.16. Siemens Healthcare GmbH
15.3.17. Stryker Corporation
15.3.18. Terumo Corporation

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Neurology Devices market report include:
  • Abbott Laboratories
  • Acandis GmbH
  • B. Braun SE
  • Boston Scientific Corporation
  • Esaote SpA
  • GE HealthCare Technologies, Inc.
  • Integra LifeSciences Holdings
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Penumbra Inc.
  • Rapid Medical Ltd.
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation

Table Information